Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Exer Joins Digital Therapeutics Alliance in Mission to Transform Global Healthcare

DENVER, Oct. 27, 2021 /PRNewswire/ -- Exer Labs, a motion-intelligence software firm committed to helping healthcare professionals deliver modern solutions in assessments, treatment, and recovery, has joined the Digital Therapeutics Alliance, whose mission is to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics with patients, clinicians, payors, and policymakers through education, advocacy, and cross-industry collaboration.

Founded in 2017, the Digital Therapeutics Alliance is a 501(c)(6) non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. As the leading international organization on digital therapeutic thought leadership and education, the Digital Therapeutics Alliance provides patients, clinicians, payors, and policymakers with the necessary tools to evaluate and utilize DTx products.

"DTA brings together leading organizations through worldwide collaboration to improve clinical and health economic outcomes by advancing the use of and reimbursement for high quality, evidence-based digital therapeutics by patients, clinicians, payors, and policymakers," said DTA CEO Andy Molnar. "We're thrilled to have Exer join our growing community as we collectively work to increase adoption of DTx products and solutions and create a healthier world."

Digital therapeutics deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to treat, manage, or prevent a disease or disorder. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.

Exer uses its motion intelligence software powered by a custom, next-generation AI that runs on any device with a 2D camera (phone, tablet, laptops, etc). The software identifies specific biomarkers on the human body which provides users and health professionals real-time data and summary metrics during exercises and functional movements. An intuitive user interface promotes engagement, adherence, and better long-term outcomes. Users simply open the app on their device, point the camera at the subject, and Exer's AI does the rest.

"We launched Exer with the goal of developing next generation software that was effective, easy to use, and delivered better outcomes for users. We've done that," said Exer CEO Zaw Thet. "Joining the DTA is an obvious next step for us to take what we've built and share it with providers and policy-makers around the world and provide another option for people in their wellness journey. We're thrilled to have found a community of like-minded people, all working to transform global healthcare."

For more information on Exer's AI-powered platform, and the technology that drives it all, visit exer.ai.

Media Contact:
Mark Jones

SOURCE Exer Labs

These press releases may also interest you

at 07:35
Geron Corporation , a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced the appointment of Edward Koval as Executive Vice President and Chief Business...

at 07:35
Omeros Corporation today announced that it has entered into a definitive agreement for the sale of OMIDRIA to Rayner Surgical Group Limited. Expected to close on or before December 31, 2021, the transaction includes an upfront payment of $125...

at 07:30
ParcelPal Logistics Inc. (the "Company" or "ParcelPal"), is pleased to announce that, as part of the Company's broader plan to continue to diversify its customer base and execute on additional profitable business engagements, it has engaged a...

at 07:30
Psyence Group Inc.  ("Psyence" or the "Company"), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that its joint venture functional mushroom brand GOODMINDtm has...

at 07:30
Drone Delivery Canada Corp. (the "Company" or "DDC") is pleased to provide a Shareholder update ? 2021 Year in Review. Dear Valued...

at 07:30
The retail self-checkout terminals market is expected to grow by USD 2.23 billion from 2020 to 2025, at a CAGR of 12.48%. The report also throws light on the new opportunities and challenges market players can expect....

News published on 27 october 2021 at 08:48 and distributed by: